DK113854B - Fremgangsmåde til fremstilling af aminoacytylener, eller syreadditionssalte heraf. - Google Patents
Fremgangsmåde til fremstilling af aminoacytylener, eller syreadditionssalte heraf.Info
- Publication number
- DK113854B DK113854B DK304861AA DK304861A DK113854B DK 113854 B DK113854 B DK 113854B DK 304861A A DK304861A A DK 304861AA DK 304861 A DK304861 A DK 304861A DK 113854 B DK113854 B DK 113854B
- Authority
- DK
- Denmark
- Prior art keywords
- aminoacytylenes
- preparation
- acid addition
- addition salts
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4529260A | 1960-07-26 | 1960-07-26 | |
| US118261A US3176019A (en) | 1960-07-26 | 1961-06-20 | Substituted aminobutynyl acetates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK113854B true DK113854B (da) | 1969-05-05 |
Family
ID=26722613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK304861AA DK113854B (da) | 1960-07-26 | 1961-07-25 | Fremgangsmåde til fremstilling af aminoacytylener, eller syreadditionssalte heraf. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3176019A (cs) |
| BE (1) | BE606560A (cs) |
| CH (1) | CH421078A (cs) |
| DE (1) | DE1216866B (cs) |
| DK (1) | DK113854B (cs) |
| ES (1) | ES269353A1 (cs) |
| FR (1) | FR1325M (cs) |
| GB (1) | GB940540A (cs) |
| NL (2) | NL124473C (cs) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5736577A (en) * | 1995-01-31 | 1998-04-07 | Sepracor, Inc. | Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin |
| US3864388A (en) * | 1970-12-29 | 1975-02-04 | Sumitomo Chemical Co | Alkynyl esters of {60 -alkoxy-{60 -phenyl alkenoic acid |
| US5036107A (en) * | 1986-06-27 | 1991-07-30 | Marion Merrell Dow Inc. | 1,7-substituted heptyn-2-ones and use |
| US4957941A (en) * | 1987-11-16 | 1990-09-18 | United Pharmaceuticals, Inc. | Anti-spasmdoic agents having an acetylenic bond |
| IL91377A (en) * | 1988-09-14 | 1996-09-12 | Nippon Shinyaku Co Ltd | Derivatives of botinylamine glycolate |
| US5677346A (en) * | 1995-01-31 | 1997-10-14 | Sepracor, Inc. | Treating urinary incontinence using (S)-desethyloxybutynin |
| US5532278A (en) * | 1995-01-31 | 1996-07-02 | Sepracor, Inc. | Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin |
| WO1998001125A2 (en) * | 1996-07-09 | 1998-01-15 | Sepracor, Inc. | Dextrorotatory isomers of oxybutynin and desethyloxybutynin in the treatment of gastrointestinal hyperactivity |
| US5973182A (en) * | 1998-10-22 | 1999-10-26 | Sepracor Inc. | Carbonate Intermediates useful in the preparation of optically active cyclohexylphenylglycolate esters |
| US6140529A (en) * | 1998-10-22 | 2000-10-31 | Sepracor Inc. | Synthesis of optically active cyclohexylphenylglycolate esters |
| EP2322170A1 (en) * | 2000-04-26 | 2011-05-18 | Watson Pharmaceuticals, Inc. | Minimizing adverse experience associated with oxybutynin therapy |
| US7179483B2 (en) | 2000-04-26 | 2007-02-20 | Watson Pharmaceuticals, Inc. | Compositions and methods for transdermal oxybutynin therapy |
| SG168451A1 (en) | 2001-10-26 | 2011-02-28 | Upjohn Co | Quarternary ammonium compounds and their use as antimuscarinic agents |
| MXPA05000434A (es) | 2002-07-08 | 2005-04-19 | Ranbaxy Lab Ltd | Derivados de hexano [3.1.0] azabiciclo 3,6-disustituido utiles como antagonistas de receptor muscarinico. |
| WO2004014853A1 (en) * | 2002-07-31 | 2004-02-19 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| AU2002321711A1 (en) * | 2002-08-09 | 2004-02-25 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives useful as muscarinic receptor antagonist |
| DE60231341D1 (de) * | 2002-08-23 | 2009-04-09 | Ranbaxy Lab Ltd | Fluor- und sulfonylaminohaltige, 3,6-disubstituierptorantagonisten |
| TW200412945A (en) | 2002-10-25 | 2004-08-01 | Upjohn Co | Quaternary ammonium compounds |
| AU2002353286A1 (en) | 2002-12-10 | 2004-06-30 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists |
| AU2002347552A1 (en) * | 2002-12-23 | 2004-07-14 | Ranbaxy Laboratories Limited | 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists |
| US7501443B2 (en) * | 2002-12-23 | 2009-03-10 | Ranbaxy Laboratories Limited | Flavaxate derivatives as muscarinic receptor antagonists |
| US7488748B2 (en) | 2003-01-28 | 2009-02-10 | Ranbaxy Laboratories Limited | 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| AU2003214520A1 (en) * | 2003-04-09 | 2004-11-01 | Ranbaxy Laboratories Limited | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| US7592359B2 (en) * | 2003-04-10 | 2009-09-22 | Ranbaxy Laboratories Limited | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| EP1615887A1 (en) | 2003-04-10 | 2006-01-18 | Ranbaxy Laboratories, Ltd. | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| WO2004089900A1 (en) * | 2003-04-11 | 2004-10-21 | Ranbaxy Laboratories Limited | Azabicyclo derivatives as muscarinic receptor antagonists |
| US20080319002A1 (en) * | 2004-06-16 | 2008-12-25 | Ranbaxy Laboratories Limited | Xanthine Derivatives a Useful as Muscarinic Receptor Antagonists |
| WO2006018708A2 (en) * | 2004-08-19 | 2006-02-23 | Ranbaxy Laboratories Limited | Pyrrolidine derivatives as muscarinic receptor antagonists |
| WO2006032994A2 (en) * | 2004-09-24 | 2006-03-30 | Ranbaxy Laboratories Limited | Muscarinic receptor antagonists |
| EP1797040A1 (en) * | 2004-09-29 | 2007-06-20 | Ranbaxy Laboratories Limited | Muscarinic receptor antagonists |
| EP1828174A1 (en) * | 2004-11-19 | 2007-09-05 | Ranbaxy Laboratories Limited | Azabicyclic muscarinic receptor antagonists |
| EP1828126A1 (en) * | 2004-12-15 | 2007-09-05 | Ranbaxy Laboratories Limited | Acid addition salts of muscarinic receptor antagonists |
| WO2006117754A1 (en) * | 2005-05-03 | 2006-11-09 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists |
| RU2008119323A (ru) | 2005-10-19 | 2009-11-27 | Рэнбакси Лабораториз Лимитед (In) | Фармацевтические композиции мускаринового рецептора |
| US20090010923A1 (en) * | 2007-04-24 | 2009-01-08 | University Of Maryland, Baltimore | Treatment of cancer with anti-muscarinic receptor agents |
| WO2009122429A2 (en) * | 2008-02-04 | 2009-10-08 | Matrix Laboratories Limited | Crystalline oxybutynin and process for preparing the same |
| AU2011245499B2 (en) | 2010-04-30 | 2014-09-25 | Merck Sharp & Dohme Corp. | Novel beta 3 adrenergic receptor agonists |
| SG187689A1 (en) | 2010-08-03 | 2013-03-28 | Altherx Inc | Combinations of beta - 3 adrenergic receptor agonists and muscarinic receptor antagonists for treating overactive bladder |
| US9907767B2 (en) | 2010-08-03 | 2018-03-06 | Velicept Therapeutics, Inc. | Pharmaceutical compositions and the treatment of overactive bladder |
| AR089957A1 (es) | 2012-02-09 | 2014-10-01 | Altherx Inc | Combinaciones farmaceuticas, combinaciones sinergicas |
| HK1245117A1 (zh) | 2014-12-03 | 2018-08-24 | Velicept Therapeutics, Inc. | 使用调节释放索拉贝隆用於下尿路症状的组合物和方法 |
| EP3365321B1 (en) | 2015-10-23 | 2023-12-13 | B3AR Therapeutics, Inc. | Solabegron zwitterion and uses thereof |
| NZ766673A (en) | 2018-01-30 | 2025-08-29 | Apnimed Inc Delaware | Methods and compositions for treating sleep apnea |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE895595C (de) * | 1943-09-29 | 1953-11-05 | Basf Ag | Verfahren zur Herstellung von Aminoalkinolen |
| DE1003209B (de) * | 1953-03-24 | 1957-02-28 | Basf Ag | Verfahren zur Herstellung spasmolytisch wirksamer basischer Carbinole |
| US2867619A (en) * | 1956-11-05 | 1959-01-06 | Lakeside Lab Inc | Aminoalkynyl-n-alkylpiperidine carboxylates |
| DE1083254B (de) * | 1957-04-01 | 1960-06-15 | Lakeside Lab In | Verfahren zur Herstellung von blutdrucksenkenden N-disubstituierten Diaminoalkinen, deren Saeureadditionssalzen oder quaternaeren Ammoniumsalzen |
| DE1100617B (de) * | 1959-10-22 | 1961-03-02 | Basf Ag | Verfahren zur Herstellung von 1-Dialkylamino-4-hydroxy-acetylenen-(2) |
-
0
- NL NL267508D patent/NL267508A/xx unknown
- NL NL124473D patent/NL124473C/xx active
-
1961
- 1961-06-20 US US118261A patent/US3176019A/en not_active Expired - Lifetime
- 1961-07-19 DE DEM49737A patent/DE1216866B/de active Pending
- 1961-07-20 FR FR868440A patent/FR1325M/fr active Active
- 1961-07-20 CH CH856161A patent/CH421078A/de unknown
- 1961-07-24 ES ES0269353A patent/ES269353A1/es not_active Expired
- 1961-07-25 GB GB26864/61A patent/GB940540A/en not_active Expired
- 1961-07-25 DK DK304861AA patent/DK113854B/da unknown
- 1961-07-26 BE BE606560A patent/BE606560A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL124473C (cs) | |
| GB940540A (en) | 1963-10-30 |
| CH421078A (de) | 1966-09-30 |
| US3176019A (en) | 1965-03-30 |
| NL267508A (cs) | |
| DE1216866B (de) | 1966-05-18 |
| FR1325M (fr) | 1962-05-21 |
| ES269353A1 (es) | 1961-11-16 |
| BE606560A (fr) | 1962-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK113854B (da) | Fremgangsmåde til fremstilling af aminoacytylener, eller syreadditionssalte heraf. | |
| DK107029C (da) | Fremgangsmåde til fremstilling af substituerede 2-arylamino-1,3-diazacycloalkener eller syreadditionssalte deraf. | |
| DK107167C (da) | Fremgangsmåde til fremstilling af benzimidazolforbindelser eller syreadditionssalte deraf. | |
| DK114903B (da) | Fremgangsmåde til fremstilling af 9,10-dihydro-ergovalin eller syreadditionssalte heraf. | |
| DK128814B (da) | Fremgangsmåde til fremstilling af benzimidazolforbindelser eller syreadditionssalte deraf. | |
| DK109037C (da) | Fremgangsmåde til fremstilling af 2-alkyl-3-hydroxy-4,5-di-hydroxymethyl-pyridiner eller syreadditionssalte deraf. | |
| DK104460C (da) | Fremgangsmåde til fremstilling af 2-methyl-3-hydroxypyridiner eller syreadditionssalte deraf. | |
| DK111564B (da) | Fremgangsmåde til fremstilling af sympathicolytisk virksomme phenoxyalkylguanidiner eller syreadditionssalte heraf. | |
| DK114559B (da) | Fremgangsmåde til fremstilling af hydroxydiaminer eller syreadditionssalte deraf. | |
| DK103672C (da) | Fremgangsmåde til fremstilling af phenylpropanolaminer eller syreadditionssalte heraf. | |
| DK102807C (da) | Fremgangsmåde til fremstilling af substituerede diphenylalkenylaminer eller syreadditionssalte heraf. | |
| DK110091C (da) | Fremgangsmåde til fremstilling af substituerede diphenylalkylaminer eller syreadditionssalte heraf. | |
| DK118189B (da) | Analogifremgangsmåde til fremstilling af benzyloxyaminer eller syreadditionssalte heraf. | |
| DK96113C (da) | Fremgangsmåde til fremstilling af o-benzylphenoxy-β-1-piperidinopropan eller syreadditionssalte deraf. | |
| DK101739C (da) | Fremgangsmåde til fremstilling af 11a-halogentetracyclin-6,12-hemiketaler eller syreadditionssalte heraf. | |
| DK101240C (da) | Fremgangsmåde til fremstilling af 1,1-dicyclohexyl-2-(2-piperidyl-ethylen eller syreadditionssalte heraf. | |
| DK105405C (da) | Fremgangsmåde til fremstilling af 5-aryl-2-amino-2-oxazolin-4-oner eller syreadditionssalte heraf. | |
| DK97884C (da) | Fremgangsmåde til fremstilling af 1-trialkoxybenzyl-piperazin eller syreadditionssalte deraf. | |
| DK102796C (da) | Fremgangsmåde til fremstilling af 6-desoxy-6-demethyl-6-methylen-11a-halogentetracycliner eller syreadditionssalte heraf. | |
| DK101689C (da) | Fremgangsmåde til fremstilling af aminopropylacridaner eller syreadditionssalte deraf. | |
| DK98126C (da) | Fremgangsmåde til fremstilling af 2-guanidin-3,4-dihydroquinazolinforbindelser eller syreadditionssalte deraf. | |
| DK96175C (da) | Fremgangsmåde til fremstilling af 9,10-dihyfroantracenderivater eller syreadditionssalte heraf. | |
| DK109748C (da) | Fremgangsmåde til fremstilling af emetinforbindelser eller syreadditionssalte deraf. | |
| DK96742C (da) | Fremgangsmåde til fremstilling af homothioxanthen-derivater eller syreadditionssalte heraf. | |
| DK98246C (da) | Fremgangsmåde til fremstilling af lysergolderivater eller syreadditionssalte heraf. |